We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment (DEMO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02590874
Recruitment Status : Completed
First Posted : October 29, 2015
Last Update Posted : October 11, 2018
Sponsor:
Information provided by (Responsible Party):
Leigh Johnson , PhD, LMSW, University of North Texas Health Science Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2017
Actual Study Completion Date : October 2018